# OnCo record sstr2 (target). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/targets/sstr2/>
  a schema:BioChemEntity ;
  onco:kind "target" ;
  schema:identifier "sstr2" ;
  schema:name "Somatostatin receptor 2"@en ;
  schema:description "Somatostatin receptor 2 is a hormone receptor densely present on neuroendocrine tumours, and was the first theranostic target to reach routine care."@en ;
  schema:url <https://onco.cc/targets/sstr2/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Somatostatin_receptor_2>, <https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:11331>, <https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000180616>, <https://www.uniprot.org/uniprotkb/P30874/entry>, <https://www.ncbi.nlm.nih.gov/gene/6752> ;
  owl:sameAs <http://www.wikidata.org/entity/Q18031731> ;
  schema:citation <https://en.wikipedia.org/wiki/Somatostatin_receptor_2> ;
  onco:tag "theranostic" ;
  schema:alternateName "SSTR2" ;
  onco:targetClass "surface-antigen" ;
  onco:firstDescribed "1992"^^xsd:gYear ;
  onco:related <https://onco.cc/biomarkers/sstr-pet-expression/> ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/alphamedix/>, <https://onco.cc/drugs/cam2029/>, <https://onco.cc/drugs/ga68-dotatate/>, <https://onco.cc/drugs/itm-11/>, <https://onco.cc/drugs/lutathera/>, <https://onco.cc/drugs/octreotide-lanreotide/>, <https://onco.cc/drugs/paltusotine/>, <https://onco.cc/drugs/pasireotide/>, <https://onco.cc/drugs/ryz101/> ;
  onco:companies <https://onco.cc/companies/point-biopharma/> .